Cases & Deals

Infinity establishes global patent portfolio for small molecule inhibitors of FAAH

Clients Infinity Pharmaceuticals, Inc.

Jones Day assists Infinity Pharmaceuticals, Inc. in the establishment of a global patent portfolio related to small molecule inhibitors of fatty acid amide hydrolase (FAAH).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.